Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
This study is testing two approaches to help people living with HIV who drink alcohol at unhealthy levels. One approach is called Acceptance and Commitment Therapy (ACT), which uses mindfulness and values-based actions to help with mental and behavioral health challenges. The other is a Brief Alcohol Intervention (BI), a standard method to reduce drinking. Researchers want to see if these interventions can help reduce how often and how much you drink. You may be able to join if you are 18 or older, living with HIV, on HIV treatment, and drink at unhealthy levels. The study aims to enroll 300 participants.
- Study design
- This is an interventional study with a planned enrollment of 300 participants. It compares two behavioral interventions: Acceptance and Commitment Therapy (ACT) and a Brief Alcohol Intervention (BI).
- What's involved
- Your alcohol use will be measured at the start, 8 weeks later, and then at 3, 6, and 12 months after the start of the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after the start of the study to measure alcohol use.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Alcohol use - FrequencyMeasured at baseline, 8 weeks post-baseline, 3-, 6- , 12-months post-baseline
The Timeline Followback will be used to estimate the Number of Drinking Days 30 days prior to study visit appointment
- Alcohol Use - QuantityMeasured at baseline, 8 weeks post-baseline, 3-, 6- , 12-months post-baseline
The Timeline Followback will be used to estimate the Number of Drinks per Drinking Day 30 days prior to study visit appointment
- Phosphatidylethanol (PEth)Measured at baseline, 8 weeks post-baseline, 3-, 6- , 12-months post-baseline
PEth is a metabolite, formed only in the presence of alcohol use and detectable in dried blood spots for approximately 3-4 weeks. The investigators will use both absolute PEth values and a cutoff of 50 mg/ml to indicate recent unhealthy alcohol use. Based on the consideration of both prevalence of underreport in the sample, the investigators will also consider using a compound measure of PEth+ (PEth ≥50ng/ml) and/or self-reported Alcohol Quantity \& Frequency via the AUDIT-C+ (≥4, men; ≥3, women) for any unhealthy alcohol use in the last 21 days as an outcome of interest.